メタ情報
| meta description平均長 | 250.41 |
|---|
| OGPありページ数 | 30 |
|---|
| Twitterカードありページ数 | 30 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 271 |
|---|
| ページあたり内部リンク平均 | 65.1 |
|---|
連絡先候補（Contacts）
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| NF1 | 1 |
| her | 0.942386 |
| trial | 0.81495 |
| trials | 0.777893 |
| clinical | 0.733319 |
| care | 0.724631 |
| has | 0.712554 |
| treatment | 0.711751 |
| patients | 0.710145 |
| your | 0.70464 |
| their | 0.615937 |
| clinic | 0.60391 |
| you | 0.600748 |
| new | 0.59561 |
| who | 0.588691 |
| our | 0.56064 |
| She | 0.526627 |
| medical | 0.525048 |
| study | 0.521568 |
| only | 0.50934 |
| will | 0.507371 |
| more | 0.507246 |
| schwannomatosis | 0.496069 |
| University | 0.48897 |
| treatments | 0.471193 |
| tumours | 0.464964 |
| people | 0.464964 |
| not | 0.462857 |
| research | 0.461406 |
| neurofibromas | 0.460831 |
| was | 0.460831 |
| healthcare | 0.460831 |
| Koselugo | 0.450359 |
| NF2 | 0.445591 |
| patient | 0.443476 |
| can | 0.437573 |
| been | 0.423183 |
| these | 0.42043 |
| tissue | 0.409417 |
| AGM | 0.409417 |
| genetic | 0.406844 |
| have | 0.399687 |
| make | 0.397764 |
| children | 0.388068 |
| drug | 0.388041 |
| criteria | 0.388041 |
| his | 0.388041 |
| now | 0.38747 |
| through | 0.38747 |
| families | 0.372453 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| Foundation | Tumour | 4.689928 | 247 |
| info | tumourfoundation | 4.429909 | 152 |
| 4R8 | V6K | 4.33603 | 124 |
| Fourth | Registration | 4.204615 | 120 |
| Toll | free | 4.174345 | 120 |
| Avenue | Fourth | 4.171086 | 124 |
| acknowledge | financial | 4.142821 | 120 |
| free | mail | 4.138686 | 120 |
| info | mail | 3.989481 | 120 |
| Registration | tumourfoundation | 3.978269 | 121 |
| V6K | Vancouver | 3.924944 | 124 |
| Province | financial | 3.820407 | 90 |
| British | Columbia | 3.766421 | 89 |
| Avenue | Vancouver | 3.760001 | 124 |
| 4R8 | Canada | 3.637426 | 124 |
| Canada | acknowledge | 3.586061 | 120 |
| Toll | mail | 3.498345 | 90 |
| 4R8 | acknowledge | 3.498345 | 90 |
| Light | Shine | 3.44023 | 40 |
| Avenue | V6K | 3.402632 | 93 |
| Foundation | Toll | 3.398392 | 120 |
| financial | support | 3.335972 | 120 |
| Award | Star | 3.316821 | 38 |
| Avenue | Registration | 3.292787 | 90 |
| Registration | info | 3.267922 | 92 |
| Province | support | 3.255992 | 90 |
| mail | tumourfoundation | 3.246413 | 90 |
| Fourth | tumourfoundation | 3.246413 | 90 |
| Fourth | Vancouver | 3.185304 | 93 |
| 4R8 | Vancouver | 3.185304 | 93 |
| free | info | 3.157713 | 90 |
| Excellence | Healthcare | 3.152409 | 32 |
| neurofibromas | plexiform | 3.094598 | 48 |
| Province | acknowledge | 3.002563 | 60 |
| British | Province | 2.960706 | 60 |
| Canada | V6K | 2.931443 | 93 |
| Toll | Tumour | 2.848373 | 90 |
| diseases | rare | 2.840207 | 29 |
| MEK | inhibitor | 2.825433 | 20 |
| acknowledge | support | 2.817395 | 90 |
| Hilton | Metrotown | 2.791079 | 33 |
| clinical | trial | 2.749154 | 63 |
| Canada | financial | 2.742178 | 90 |
| Award | Healthcare | 2.739509 | 28 |
| Authority | Special | 2.735929 | 20 |
| provinces | territories | 2.735929 | 20 |
| Children | Hospital | 2.733982 | 31 |
| Progressing | Refractory | 2.729334 | 16 |
| above | beyond | 2.724974 | 28 |
| been | has | 2.720775 | 86 |